blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0348490

EP0348490 - TREATMENT OF TYPE 2 DIABETES MELLITUS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.08.1996
Database last updated on 11.09.2024
Most recent event   Tooltip02.08.1996No opposition filed within time limitpublished on 18.09.1996 [1996/38]
Applicant(s)For all designated states
AMYLIN PHARMACEUTICALS, INC.
9373 Towne Centre Drive, Suite 250 San Diego
California 92121 / US
[N/P]
Former [1995/31]For all designated states
AMYLIN PHARMACEUTICALS, INC.
9373 Towne Centre Drive, Suite 250
San Diego California 92121 / US
Former [1990/01]For all designated states
AMYLIN CORPORATION
12520 High Bluff Drive Suite 250
San Diego California 92130 / US
Inventor(s)01 / COOPER, Garth, James, Smith
The Cardinal's Hat Chaucer's Lane
Woodstock Oxon OX7 1SR / GB
02 / GREENE, Howard, E.
6336 Calle del Alcazar
Rancho Santa Fe, CA 92067 / US
[1990/01]
Representative(s)Baillie, Iain Cameron, et al
Ladas & Parry, Dachauerstrasse 37
80335 München / DE
[N/P]
Former [1990/01]Baillie, Iain Cameron, et al
c/o Ladas & Parry Altheimer Eck 2
D-80331 München / DE
Application number, filing date89901802.211.01.1989
[1990/01]
WO1989US00049
Priority number, dateUS1988014244711.01.1988         Original published format: US 142447
[1990/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO8906135
Date:13.07.1989
Language:EN
[1989/15]
Type: A1 Application with search report 
No.:EP0348490
Date:03.01.1990
Language:EN
The application published by WIPO in one of the EPO official languages on 13.07.1989 takes the place of the publication of the European patent application.
[1990/01]
Type: B1 Patent specification 
No.:EP0348490
Date:27.09.1995
Language:EN
[1995/39]
Search report(s)International search report - published on:US13.07.1989
(Supplementary) European search report - dispatched on:EP23.06.1992
ClassificationIPC:A61K38/00, C07K7/08, C07K14/00
[1995/39]
CPC:
C07K16/26 (EP); A61P3/08 (EP); A61P3/10 (EP);
C07K14/575 (EP); A61K38/00 (EP); H01L2924/01023 (EP)
Former IPC [1990/01]A61K37/02, C07K7/08, C07K7/10
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1990/01]
TitleGerman:BEHANDLUNG VON DIABETES MELLITUS TYP 2[1990/01]
English:TREATMENT OF TYPE 2 DIABETES MELLITUS[1990/01]
French:TRAITEMENT DU DIABETE SUCRE DU TYPE 2[1990/01]
Entry into regional phase27.09.1989National basic fee paid 
27.09.1989Search fee paid 
27.09.1989Designation fee(s) paid 
02.01.1990Examination fee paid 
Examination procedure02.01.1990Examination requested  [1990/10]
10.02.1993Despatch of a communication from the examining division (Time limit: M06)
24.09.1993Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
25.11.1993Reply to a communication from the examining division
16.02.1994Despatch of a communication from the examining division (Time limit: M04)
17.06.1994Reply to a communication from the examining division
09.11.1994Despatch of communication of intention to grant (Approval: Yes)
14.03.1995Communication of intention to grant the patent
14.06.1995Fee for grant paid
14.06.1995Fee for publishing/printing paid
Opposition(s)28.06.1996No opposition filed within time limit [1996/38]
Request for further processing for:25.11.1993Request for further processing filed
25.11.1993Full payment received (date of receipt of payment)
Request granted
21.01.1994Decision despatched
Fees paidRenewal fee
31.12.1990Renewal fee patent year 03
30.12.1991Renewal fee patent year 04
22.12.1992Renewal fee patent year 05
20.12.1993Renewal fee patent year 06
10.01.1995Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0270376  (TOYO JOZO KK [JP]);
 [A]EP0289287  (AMYLIN CORP [US])
International search[X]  - Biological Abstracts, Vol. 84, issued 01 November 1987 (CLARK), "Islet Amyloid Formed from Diabetes Associated Peptide maybe Pathogenic in Type-2 Diabetes". Abstract No. 86506.
 [XP]  - CHEMICAL ABSTRACTS, Vol. 109, issued 05 December 1988 (Columbus, Oh.) "Pancreatic Amylin and Calcitonin Gene-Related Peptide cause Resistance to Insulin in Skeletal Muscle in Vitro". (LEIGHTON) Abstract No. 205686u
 [XP]  - CHEMICAL ABSTRACTS, Vol. 110, issued 02 January 1989 (Columbus, Oh.) "Amylin found in Amyloid Deposits in Human Type 2 Diabetes Mellitus may be a Hormone that Regulates Glycogen Metabolism in Skeletal Muscle". (COOPER) Abstract No. 5630e.
Examination   - "Pancreatic Amylin and Calcitonin Gene-Related Peptide cause Resistance toInsulin in Skeletal Muscle in Vitro". (LEIGHTON) Abstract No. 205686u
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.